Edition:
United States

Geron Corp (GERN.O)

GERN.O on Nasdaq

1.44USD
22 Aug 2019
Change (% chg)

$0.02 (+1.41%)
Prev Close
$1.42
Open
$1.41
Day's High
$1.46
Day's Low
$1.39
Volume
1,320,851
Avg. Vol
1,759,146
52-wk High
$6.99
52-wk Low
$0.95

About

Geron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company is engaged in the development of therapeutic products for oncology. Using its nucleic acid chemistry,... (more)

Overall

Beta: 2.53
Market Cap(Mil.): $220.09
Shares Outstanding(Mil.): 186.52
Dividend: --
Yield (%): --

Financials

  GERN.O Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -0.16 -- --
ROI: -22.10 7.52 12.69
ROE: -22.10 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates